MCID: PLR005
MIFTS: 47

Pleuropneumonia

Categories: Respiratory diseases

Aliases & Classifications for Pleuropneumonia

MalaCards integrated aliases for Pleuropneumonia:

Name: Pleuropneumonia 12 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:14319
MeSH 44 D011001
SNOMED-CT 68 60485005
UMLS 73 C0032241

Summaries for Pleuropneumonia

Disease Ontology : 12 A pneumonia accompanied by inflammation of the pleura and accumulation of pus in the pleural space caused by bacteria.

MalaCards based summary : Pleuropneumonia is related to salpingitis and granulomatous hepatitis. An important gene associated with Pleuropneumonia is SNORD50A (Small Nucleolar RNA, C/D Box 50A), and among its related pathways/superpathways are Akt Signaling and IL-2 Pathway. The drugs Azithromycin and Doxycycline have been mentioned in the context of this disorder. Affiliated tissues include testes, lung and colon, and related phenotypes are hematopoietic system and immune system

Wikipedia : 76 Pleuropneumonia is inflammation of the lungs and pleura, pleurisy being the inflammation of the pleura... more...

Related Diseases for Pleuropneumonia

Diseases related to Pleuropneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 121)
# Related Disease Score Top Affiliating Genes
1 salpingitis 29.6 CD40LG CD79A
2 granulomatous hepatitis 29.5 CD40LG CD79A GGT1
3 hemoglobin lepore-beta-thalassemia syndrome 10.7 HBB HBD
4 hemoglobin d disease 10.7 HBB HBD
5 malignant secondary hypertension 10.6 HBB HBD
6 hemoglobin e disease 10.6 HBB HBD
7 hemoglobin c disease 10.6 HBB HBD
8 osgood-schlatter's disease 10.6 HBB HBD
9 maxillary sinusitis 10.5 CD79A IRAK4
10 spastic paraplegia 32, autosomal recessive 10.3 FCGR3A FCGR3B
11 scleredema adultorum 10.3 CD79A CXCL9
12 fetal hemoglobin quantitative trait locus 1 10.3 HBB HBD
13 selective igg deficiency disease 10.2 CD40LG CD79A
14 c1q nephropathy 10.2 CD40LG CD79A
15 meningovascular neurosyphilis 10.2 CD40LG CD79A
16 alpha chain disease 10.2 CD40LG CD79A
17 brill-zinsser disease 10.2 CD40LG CD79A
18 exudative glomerulonephritis 10.2 CD40LG CD79A
19 cork-handlers' disease 10.2 CD40LG CD79A
20 salpingo-oophoritis 10.2 CD40LG CD79A
21 early yaws 10.2 CD40LG CD79A
22 ventilation pneumonitis 10.2 CD40LG CD79A
23 chronic interstitial cystitis 10.2 CD40LG CD79A
24 axillary adenitis 10.2 CD40LG CD79A
25 cryofibrinogenemia 10.2 CD40LG CD79A
26 trichostrongyloidiasis 10.2 CD40LG CD79A
27 subacute bacterial endocarditis 10.2 CD40LG CD79A
28 heterophyiasis 10.2 CD40LG CD79A
29 schnitzler syndrome 10.2 CD40LG IL1R1
30 immunoglobulin g deficiency 10.2 CD40LG CD79A
31 orbital granuloma 10.2 CD40LG CD79A
32 transient hypogammaglobulinemia of infancy 10.2 CD40LG CD79A
33 hyperglobulinemic purpura 10.2 CD40LG CD79A
34 gastroduodenitis 10.2 CD40LG CD79A
35 bacterial conjunctivitis 10.2 CD40LG CD79A
36 ophthalmia neonatorum 10.2 CD40LG CD79A
37 immunoglobulin a deficiency 1 10.2 CD40LG CD79A
38 parotid disease 10.2 CD40LG CD79A
39 cerebral arteritis 10.1 CD40LG CD79A
40 pneumonia 10.1
41 selective immunoglobulin deficiency disease 10.1 CD40LG CD79A
42 geniculate herpes zoster 10.1 CD40LG CD79A
43 erythema elevatum diutinum 10.1 CD40LG CD79A
44 sporotrichosis 10.1 CD40LG CD79A
45 fallopian tube disease 10.1 CD40LG CD79A
46 hyperimmunoglobulin syndrome 10.1 CD40LG CD79A
47 congenital syphilis 10.1 CD40LG CD79A
48 transient neonatal neutropenia 10.1 CD79A FCGR3A FCGR3B
49 polyclonal hypergammaglobulinemia 10.1 CD40LG CD79A
50 chronic orbital inflammation 10.1 CD79A FCGR3A FCGR3B

Graphical network of the top 20 diseases related to Pleuropneumonia:



Diseases related to Pleuropneumonia

Symptoms & Phenotypes for Pleuropneumonia

MGI Mouse Phenotypes related to Pleuropneumonia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 CD79A FCGR3B GGT1 IL1R1 IRAK1 IRAK3
2 immune system MP:0005387 9.65 CD40LG CD79A FCGR3B GGT1 IL1R1 IRAK1
3 skeleton MP:0005390 9.23 CD40LG COL18A1 FCGR3B GGT1 IL1R1 IRAK3

Drugs & Therapeutics for Pleuropneumonia

Drugs for Pleuropneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 127)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 83905-01-5 55185 447043
2
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 564-25-0 54671203
3
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
4
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
5
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
6
Ofloxacin Approved Phase 4 82419-36-1 4583
7
Methylprednisolone Approved, Vet_approved Phase 4,Not Applicable 83-43-2 6741
8
Prednisolone Approved, Vet_approved Phase 4,Not Applicable 50-24-8 5755
9 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
10 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
11 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
12 Antimalarials Phase 4,Phase 3,Phase 2,Not Applicable
13 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Not Applicable
14 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Not Applicable
15 Antitubercular Agents Phase 4,Phase 3,Phase 2,Not Applicable
16 Anti-Inflammatory Agents Phase 4,Not Applicable
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2
18 Gastrointestinal Agents Phase 4,Phase 2,Not Applicable
19 Peripheral Nervous System Agents Phase 4,Not Applicable
20 Autonomic Agents Phase 4,Not Applicable
21 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
22 Renal Agents Phase 4,Phase 2
23 Topoisomerase Inhibitors Phase 4,Not Applicable
24 Antiemetics Phase 4,Not Applicable
25 Antineoplastic Agents, Hormonal Phase 4,Not Applicable
26 glucocorticoids Phase 4,Not Applicable
27 Hormone Antagonists Phase 4,Not Applicable
28 Hormones Phase 4,Not Applicable
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Not Applicable
30 Methylprednisolone acetate Phase 4,Not Applicable
31 Methylprednisolone Hemisuccinate Phase 4,Not Applicable
32 Neuroprotective Agents Phase 4,Not Applicable
33 Prednisolone acetate Phase 4,Not Applicable
34 Prednisolone hemisuccinate Phase 4,Not Applicable
35 Prednisolone phosphate Phase 4,Not Applicable
36 Protective Agents Phase 4,Not Applicable
37 Carboxymethylcellulose Sodium Phase 4
38 Cathartics Phase 4
39 Laxatives Phase 4
40
Clarithromycin Approved Phase 3,Phase 2 81103-11-9 84029
41
Josamycin Approved, Investigational Phase 3 16846-24-5 5282165
42
Ceftriaxone Approved Phase 3 73384-59-5 5479530 5361919
43
Cefixime Approved, Investigational Phase 3 79350-37-1 54362 5362065
44 Cytochrome P-450 CYP3A Inhibitors Phase 3,Phase 2
45 Cephalosporins Phase 3,Not Applicable
46 beta-Lactams Phase 3
47 Lactams Phase 3
48
Tinidazole Approved, Investigational Phase 2 19387-91-8 5479
49
Basiliximab Approved, Investigational Phase 2 152923-56-3, 179045-86-4
50
Infliximab Approved Phase 2 170277-31-3

Interventional clinical trials:

(show top 50) (show all 63)
# Name Status NCT ID Phase Drugs
1 Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner Unknown status NCT01555047 Phase 4
2 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
3 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
4 Microorganism in Overactive Bladder Patients Completed NCT00883818 Phase 4 azithromycin, doxycycline
5 AZithromycin Against pLacebo in Exacerbations of Asthma Completed NCT01444469 Phase 4 Zithromax;Placebo
6 Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia Recruiting NCT02618057 Phase 4 Prednisolone;Levofloxacin
7 Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study Terminated NCT01879930 Phase 4 doxycycline;placebo
8 Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis Unknown status NCT01652118 Phase 3 clarithromycin treatment for prophylaxis of bronchopulmonary dysplasia;Saline
9 Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA) Completed NCT00358462 Phase 3 Azithromycin;Doxycycline
10 Antibiotic Treatment of Gulf War Veterans' Illnesses Completed NCT00007735 Phase 3 Doxycycline (200mg/day) or Placebo
11 Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin) Completed NCT00718705 Phase 3 Josamycin;Placebo
12 Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia Completed NCT00509106 Phase 3 Ceftaroline fosamil for Injection;Ceftriaxone;Placebo
13 Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia Completed NCT00621504 Phase 3 Ceftaroline fosamil for Injection;IV Ceftriaxone;Placebo;Clarithromycin
14 Empiric Therapy of Mucopurulent Cervicitis (MPC) Terminated NCT01072136 Phase 3 Azithromycin;Cefixime
15 TINN2: Treat Infection in NeoNates 2 Withdrawn NCT02282176 Phase 3 Azithromycin;Placebo
16 Antibiotic Treatment Trial for the PANDAS/PANS Phenotype Completed NCT01617083 Phase 2 Azithromycin;Placebo
17 A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH) Completed NCT01198418 Phase 1, Phase 2
18 NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Completed NCT00322465 Phase 2 Tinidazole;Doxycycline;Azithromycin
19 Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease Recruiting NCT02770430 Phase 2 conventional treatment
20 Autologous Dendritic Cell Vaccination in Mesothelioma Recruiting NCT02649829 Phase 1, Phase 2
21 Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients Recruiting NCT02649582 Phase 1, Phase 2
22 A Novel Regimen to Prevent Malaria and STI in Pregnant Women With HIV Recruiting NCT03431168 Phase 2 Azithromycin/TMPS;Placebo/TMPS
23 Aralast NP in Islet Transplant Active, not recruiting NCT02520076 Phase 1, Phase 2 Alpha-1 Antitrypsin
24 Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW) Terminated NCT01851954 Phase 2 Clarithromycin
25 Mecillinam for Treatment of Genital Chlamydia Infection Terminated NCT02083276 Phase 2 Pivmecillinamhydrochlorid
26 NSAIDs Treatment in Children With Pleuropneumonia Unknown status NCT01586299 Not Applicable Ibuprofen;Acetaminophen
27 Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy Unknown status NCT01281319
28 Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis Unknown status NCT00926601
29 The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults Unknown status NCT01801657
30 Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia Unknown status NCT02362906 Not Applicable Xiyanping injection;wind-heat formula granules;phlegm-heat formula granules;Fu-xiong San;second generation cephalosporin;Erythromycin;Azithromycin
31 300 Antibody Diagnostic Test Kit Unknown status NCT01646411
32 Detection of Mycoplasma Pneumoniae Completed NCT02511262
33 Chlamydia and Mycoplasma in Coronary Artery Disease Completed NCT00561028
34 Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting Completed NCT00207584 Not Applicable Doxycycline treatment
35 The Optimization of Mycoplasm Pneumonia Antibiotic Therapy Completed NCT01259141 Not Applicable Moxifloxacin;Cephalosporins and azithromycin
36 Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms Completed NCT01559623
37 Etiology of Community Acquired Pneumonia Completed NCT00471757
38 Community-Acquired Pneumonia (CAP) Surveillance Completed NCT01416506
39 Rewarding Sexually Transmitted Infection (STI) Prevention and Control in Tanzania Completed NCT00922038 Not Applicable
40 Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Completed NCT01843946
41 Levofloxacin in Bacterial Rhinosinussitis Completed NCT02712502 Levofloxacin;Amoxicillin-Potassium Clavulanate Combination
42 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
43 Use of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired Pneumonia Completed NCT02523885
44 Treatment of Macrolide-resistant Mycoplasma Pneumoniae Recruiting NCT03530319 Not Applicable Doxycycline;Azithromycin
45 Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples, in Men Who Have Sex With Men Recruiting NCT03568695 Not Applicable
46 Methylprednisolone for Children With Severe Mycoplasma Pneumoniae Pneumonia (MCMP) Recruiting NCT02303587 Not Applicable methylprednisolone
47 Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia Recruiting NCT03527992 Not Applicable
48 Prevalence of Sexually Transmitted Infections Among People Attending the Sexual Assault Centre in Oslo, Norway. Recruiting NCT03132389
49 Assessment of Pharyngeal Carriage of Microorganisms Responsible for Transmissible Acute Respiratory Infections in HAJJ Pilgrims. Recruiting NCT02868541
50 Etiology Study of Kawasaki Disease Recruiting NCT00154596

Search NIH Clinical Center for Pleuropneumonia

Cochrane evidence based reviews: pleuropneumonia

Genetic Tests for Pleuropneumonia

Anatomical Context for Pleuropneumonia

MalaCards organs/tissues related to Pleuropneumonia:

41
Testes, Lung, Colon, Liver, Prostate, Kidney, B Cells

Publications for Pleuropneumonia

Articles related to Pleuropneumonia:

(show top 50) (show all 584)
# Title Authors Year
1
Perceptions, circumstances and motivators affecting the implementation of contagious bovine pleuropneumonia control programmes in Nigerian Fulani pastoral herds. ( 29290302 )
2018
2
Improving quality control of Contagious Caprine Pleuropneumonia vaccine with tandem mass spectrometry. ( 29911326 )
2018
3
Polymorphonuclear cells and reactive oxygen species in contagious bovine pleuropneumonia: New insight from in vitro investigations. ( 29914676 )
2018
4
Contagious Bovine Pleuropneumonia: Seroprevalence and Risk Factors in Gimbo District, Southwest Ethiopia. ( 29977494 )
2018
5
In this issue - January/February 2018: Global challenges for Australian veterinariansa88A^a88Financial stress in veterinary studentsa88A^a88Genetic diversity of A. pleuropneumoniae serovarsa88A^a88Sequencing of canid alphaherpesvirus 1 a88A^a88Rib pivot lateral thoracotomya88A^a88Medical management of pseudomembranous cystitis in catsa88A^a88Recumbency and inspired O<sub>2</sub>concentration in anaesthetised horsesa88A^a88Practitioner preferences for equine castration. ( 29377086 )
2018
6
Respiratory explants as a model to investigate early events of contagious bovine pleuropneumonia infection. ( 29329577 )
2018
7
Efficacy of a one-shot marbofloxacin treatment on acute pleuropneumonia after experimental aerosol inoculation of nursery pigs. ( 29977591 )
2018
8
Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. ( 28090673 )
2017
9
Lung lesion score system in cattle: proposal for contagious bovine pleuropneumonia. ( 28951993 )
2017
10
The value of molecular techniques to diagnose Ureaplasma urealyticum and Nocardia farcinica Pleuropneumonia in a Patient with Diffuse large B-Cell Lymphoma. ( 28951103 )
2017
11
Ultrasonographic findings in goats with contagious caprine pleuropneumonia caused by Mycoplasma capricolum subsp. capripneumoniae. ( 28830505 )
2017
12
B cell cross-epitope of Propionibacterium acnes and Actinobacillus pleuropneumonia selected by phage display library can efficiently protect from Actinobacillus pleuropneumonia infection. ( 28622855 )
2017
13
Policy analysis for delivery of contagious bovine pleuropneumonia control strategies in sub-Saharan Africa. ( 28926016 )
2017
14
Pig Lung Immune Cytokine Response to the Swine Influenza Virus and the <i>Actinobacillus Pleuropneumoniae</i> Infection. ( 29978082 )
2017
15
Contagious caprine pleuropneumonia: The first isolation and molecular characterization of Mycoplasma capricolum subsp. capripneumoniae in the Kingdom of Saudi Arabia. ( 28111131 )
2017
16
Factors Associated with Survival in 97 Horses with Septic Pleuropneumonia. ( 28271546 )
2017
17
Thoracic splenosis mimicking a pleuropneumonia: A case report. ( 28723778 )
2017
18
Seroprevalence and Distribution of Contagious Bovine Pleuropneumonia in Ethiopia: Update and Critical Analysis of 20 Years (1996-2016) Reports. ( 28702460 )
2017
19
Kinetics of single and dual infection of pigs with swine influenza virus and Actinobacillus pleuropneumoniae. ( 28284596 )
2017
20
Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia. ( 27496744 )
2016
21
A meta-analysis of contagious caprine pleuropneumonia (CCPP) in Ethiopia. ( 26943994 )
2016
22
Community-acquired pleuropneumonia in children: Bacteriological and therapeutic challenges. ( 27704513 )
2016
23
Complete Genome Sequence of Mycoplasma mycoides subsp. mycoides T1/44, a Vaccine Strain against Contagious Bovine Pleuropneumonia. ( 27081135 )
2016
24
Recombinant Mycoplasma mycoides proteins elicit protective immune responses against contagious bovine pleuropneumonia. ( 26964722 )
2016
25
Coinfection by Ureaplasma spp., Photobacterium damselae and an Actinomyces-like microorganism in a bottlenose dolphin (Tursiops truncatus) with pleuropneumonia stranded along the Adriatic coast of Italy. ( 27033917 )
2016
26
A contagious bovine pleuropneumonia outbreak on a research farm in Ethiopia, and its dynamics over an eight-month period. ( 28332650 )
2016
27
Morphological characterization and immunohistochemical detection of the proinflammatory cytokines IL-1I^, IL-17A, and TNF-I+ in lung lesions associated with contagious bovine pleuropneumonia. ( 26837619 )
2016
28
Contagious bovine pleuropneumonia: Seroprevalence and risk factors in Western Oromia, Ethiopia. ( 27247066 )
2016
29
Development of a Novel Cocktail Enzyme-Linked Immunosorbent Assay and a Field-Applicable Lateral-Flow Rapid Test for Diagnosis of Contagious Bovine Pleuropneumonia. ( 27053669 )
2016
30
Surface Polysaccharide Mutants Reveal that Absence of O Antigen Reduces Biofilm Formation of Actinobacillus pleuropneumoniae. ( 26483403 )
2016
31
Qualitative and quantitative impacts assessment of contagious bovine pleuropneumonia in Fulani pastoral herds of North-central Nigeria: The associated socio-cultural factors. ( 27237398 )
2016
32
Therapeutic effect of Chinese patent medicine &amp;quot;Wuhuanghu&amp;quot; on porcine infectious pleuropneumonia and its acute and subchronic toxicity as well as evaluation of safety pharmacology. ( 26245812 )
2015
33
Analysis of immune responses to recombinant proteins from strains of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia. ( 26384697 )
2015
34
Update on Bacterial Pneumonia and Pleuropneumonia in the Adult Horse. ( 25600453 )
2015
35
Sero-prevalence of Contagious Bovine Pleuropneumonia (CBPP) in bulls originated from Borena pastoral area of Southern Ethiopia. ( 25863957 )
2015
36
Streptococcus equi subsp zooepidemicus pleuropneumonia and peritonitis in a dromedary camel (Camelus dromedarius) calf in North America. ( 26176731 )
2015
37
Mathematical modelling of the transmission dynamics of contagious bovine pleuropneumonia reveals minimal target profiles for improved vaccines and diagnostic assays. ( 25668725 )
2015
38
Whole-Genome Sequencing of Mycoplasma mycoides subsp. mycoides Italian Strain 57/13, the Causative Agent of Contagious Bovine Pleuropneumonia. ( 25814605 )
2015
39
The Use of Recombinant Tissue Plasminogen Activator (rTPA) in The Treatment of Fibrinous Pleuropneumonia in Horses: 25 Cases (2007-2012). ( 26256909 )
2015
40
Proteomic characterization of pleural effusion, a specific host niche of Mycoplasma mycoides subsp. mycoides from cattle with contagious bovine pleuropneumonia (CBPP). ( 26476145 )
2015
41
Seroprevalence of contagious bovine pleuropneumonia (CBPP) in Mali. ( 25433650 )
2015
42
Isolation and Phylogenetic Characterization of Streptococcus halichoeri from a European Badger (Meles meles) with Pyogranulomatous Pleuropneumonia. ( 25678424 )
2015
43
Non-haemolytic Mannheimia haemolytica as a cause of pleuropneumonia and septicemia in a calf. ( 26344042 )
2015
44
Abattoir surveillance demonstrates contagious bovine pleuropneumonia is widespread in Tanzania. ( 26315150 )
2015
45
Sero-positivity and associated risk factors for contagious bovine pleuropneumonia under two cattle production systems in North Central Nigeria. ( 26563271 )
2015
46
Quantitative risk assessment of entry of contagious bovine pleuropneumonia through live cattle imported from northwestern Ethiopia. ( 26427634 )
2015
47
The Association of Fibrinous Pleural Effusion with Survival and Complications in Horses with Pleuropneumonia (2002-2012): 74 Cases. ( 26259510 )
2015
48
Participatory Epidemiology of Ethnoveterinary Practices Fulani Pastoralists Used to Manage Contagious Bovine Pleuropneumonia and Other Cattle Ailments in Niger State, Nigeria. ( 26464953 )
2015
49
A large-scale genomic approach affords unprecedented resolution for the molecular epidemiology and evolutionary history of contagious caprine pleuropneumonia. ( 26149260 )
2015
50
Serological prevalence of contagious bovine pleuropneumonia in agro-pastoral areas of Nigeria. ( 25894821 )
2015

Variations for Pleuropneumonia

Expression for Pleuropneumonia

Search GEO for disease gene expression data for Pleuropneumonia.

Pathways for Pleuropneumonia

Pathways related to Pleuropneumonia according to GeneCards Suite gene sharing:

(show all 20)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.26 CD40LG CXCL9 IL1R1 IRAK1 IRAK3 IRAK4
2
Show member pathways
12.67 CD79A IL1R1 IRAK1 IRAK3 IRAK4 MYD88
3
Show member pathways
12.57 CD40LG IL1R1 IRAK1 IRAK3 IRAK4 MYD88
4 12.31 CD40LG CD79A IRAK1 IRAK3 IRAK4 MYD88
5
Show member pathways
12.29 IRAK1 IRAK3 IRAK4 MYD88
6
Show member pathways
12.26 IRAK1 IRAK3 IRAK4 MYD88
7
Show member pathways
12.16 IL1R1 IRAK1 IRAK3 IRAK4 MYD88
8
Show member pathways
12.13 IRAK1 IRAK3 IRAK4 MYD88
9
Show member pathways
12.1 IL1R1 IRAK1 IRAK3 IRAK4 MYD88
10
Show member pathways
12.08 IL1R1 IRAK1 IRAK4 MYD88
11 12.08 FCGR3A FCGR3B IRAK1 IRAK4 MYD88
12
Show member pathways
11.98 IL1R1 IRAK1 IRAK3 IRAK4 MYD88
13 11.87 FCGR3A FCGR3B IL1R1
14
Show member pathways
11.7 CD40LG FCGR3A FCGR3B IRAK1 IRAK4 MYD88
15
Show member pathways
11.63 CD40LG IL1R1 IRAK1 IRAK3 IRAK4 MYD88
16 11.61 IRAK1 IRAK4 MYD88
17 11.53 CD40LG IL1R1 IRAK1 IRAK4 MYD88
18 11.39 CD40LG HBB MYD88
19 11.29 IL1R1 IRAK1 IRAK3 MYD88
20 11.07 IL1R1 IRAK1 MYD88

GO Terms for Pleuropneumonia

Cellular components related to Pleuropneumonia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 CD40LG CELA3B COL18A1 CXCL9 GGT1 HBB
2 hemoglobin complex GO:0005833 9.16 HBB HBD
3 external side of plasma membrane GO:0009897 9.02 CD40LG CD79A CXCL9 FCGR3A IL1R1

Biological processes related to Pleuropneumonia according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.91 CD40LG CXCL9 FCGR3A FCGR3B IL1R1
2 cytokine-mediated signaling pathway GO:0019221 9.8 IL1R1 IRAK1 IRAK3 IRAK4 MYD88
3 response to lipopolysaccharide GO:0032496 9.78 CXCL9 IRAK1 IRAK3 MYD88
4 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.72 CD40LG IRAK1 IRAK3 IRAK4 MYD88
5 regulation of inflammatory response GO:0050727 9.7 GGT1 IL1R1 MYD88
6 positive regulation of smooth muscle cell proliferation GO:0048661 9.63 IRAK1 IRAK4 MYD88
7 JNK cascade GO:0007254 9.61 IRAK1 IRAK4 MYD88
8 toll-like receptor signaling pathway GO:0002224 9.56 IRAK1 IRAK3 IRAK4 MYD88
9 oxygen transport GO:0015671 9.54 HBB HBD
10 toll-like receptor 9 signaling pathway GO:0034162 9.54 IRAK1 IRAK4 MYD88
11 response to peptidoglycan GO:0032494 9.49 IRAK3 MYD88
12 MyD88-dependent toll-like receptor signaling pathway GO:0002755 9.46 IRAK1 IRAK3 IRAK4 MYD88
13 response to interleukin-1 GO:0070555 9.26 IL1R1 IRAK1 IRAK3 MYD88
14 interleukin-1-mediated signaling pathway GO:0070498 9.02 IL1R1 IRAK1 IRAK3 IRAK4 MYD88

Molecular functions related to Pleuropneumonia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 interleukin-1 receptor binding GO:0005149 9.16 IRAK4 MYD88
2 oxygen carrier activity GO:0005344 8.96 HBB HBD
3 IgG binding GO:0019864 8.62 FCGR3A FCGR3B

Sources for Pleuropneumonia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....